NAVDEEP PUREWAL: Open Payments
NPI 1881663094 · BRIDGEVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$451 in 25 payments from 6 companies in 2025. Trend: 2023 $423 · 2024 $79 · 2025 $451
Food & beverage: $451
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $151 |
| Collegium Pharmaceutical, Inc. | 5 | $93 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $90 |
| Alkermes, Inc. | 3 | $77 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
Products named: VRAYLAR, Jornay PM, CAPLYTA, LYBALVI, FANAPT, ARISTADA, AUSTEDO XR.
Industry payments across PA — which companies pay providers there.
